FHTX compared with GENB: revenue, margins and what each company keeps, and the suppliers and customers both name

FHTXFoghorn Therapeutics Inc.

Mkt capRevenueRevenue

GENBGenerate Biomedicines, Inc.

Mkt capRevenueRevenue

Compare

FHTXFoghorn Therapeutics Inc.

GENBGenerate Biomedicines, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only FHTX 2

LLYEli Lillycustomer

MRKMerck Sharp & Dohmecustomer

Shared 0

No shared counterparties.

Only GENB 4

AMGNAmgencustomer

NVSNovartis Pharmacustomer

—The University of Texas MD Anderson Cancer Centerunlistedsupplier

—Roswell Park Comprehensive Cancer Center

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

FHTXFoghorn Therapeutics Inc.

2.08▼−0.48%· post 2.08

Mkt cap$123.5MRevenue$16MQ2 FY26Revenue$31MFY25

GENBGenerate Biomedicines, Inc.

14.49▼−8.10%· post 14.49

ClosedOct 30 '26

Mkt cap$1.9BRevenue$6MQ2 FY26Revenue—

Compare

ClosedOct 30 '26

FHTXFoghorn Therapeutics Inc.

GENBGenerate Biomedicines, Inc.

2.08▼−0.48%post 2.08

Price

14.49▼−8.10%post 14.49

$123.5M

Mkt cap

$1.9B

Q2 FY26$16M

Revenue

$6MQ2 FY26

FY25$31M

Revenue

—

FHTX2.08▼−0.48%vsGENB14.49▼−8.10%ClosedOct 30 '26